AstraZeneca

Biopharmaceuticals · Prescription Medicines · Cambridge, England

AstraZeneca is a global biopharmaceutical company that researches, develops and commercialises prescription medicines. Its portfolio spans oncology, rare disease and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology, and infectious disease. Its medicines serve patients through healthcare professionals and health systems worldwide.

For 2025 it reported total revenue of USD 58.7 billion, made up mainly of product sales with a smaller share of alliance revenue from partnered products. AstraZeneca PLC was incorporated in England and Wales in 1992, has its headquarters in Cambridge, UK, and its shares trade on the London Stock Exchange and the New York Stock Exchange.